Basic Information
| LncRNA/CircRNA Name | XIST |
| Synonyms | NA |
| Region | GRCh38_X:73820651-73852753 |
| Ensemble | ENSG00000229807 |
| Refseq | NR_001564 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | cervical cancer tissues, cell lines (Hela and C33A) |
| Expression Pattern | up-regulated |
| Function Description | Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. |
| Pubmed ID | 30858762 |
| Year | 2019 |
| Title | Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. |
External Links
| Links for XIST | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |